EyePoint Pharmaceuticals, Inc. (EYPT)
USD 6.47
(9.66%)
USD 6.47
(9.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.87 Million | -65 Million | -50.09 Million | -14.43 Million | -56.69 Million | -21.9 Million |
| Net Income | -70.79 Million | -102.25 Million | -58.41 Million | -45.39 Million | -56.79 Million | -53.17 Million |
| Depreciation & Amortization | 464 Thousand | 2.44 Million | 2.77 Million | 2.64 Million | 2.6 Million | 1.14 Million |
| Deferred income taxes | 83 Thousand | - | -787 Thousand | 905 Thousand | 3.81 Million | 26.27 Million |
| Stock-based compensation | 12.05 Million | 14.17 Million | 7.44 Million | 5.54 Million | 4.56 Million | 3.96 Million |
| Change in working capital | 58.88 Million | -3.02 Million | -1.73 Million | 20.13 Million | -12.53 Million | 925 Thousand |
| Other non-cash items | 1.18 Million | 23.64 Million | 628 Thousand | 1.72 Million | 1.64 Million | 209 Thousand |
| Investing Cash Flow | -3.31 Million | -17.26 Million | -33.12 Million | -362 Thousand | -213 Thousand | -16.88 Million |
| Investments in PPE | -3.48 Million | -2.15 Million | -156 Thousand | -362 Thousand | -213 Thousand | -108 Thousand |
| Acquisitions | -168 Thousand | -558 Thousand | - | - | - | -16.78 Million |
| Investment purchases | -55.11 Million | -139.11 Million | -32.96 Million | - | - | - |
| Sales/Maturities of investments | 55.28 Million | 124 Million | - | - | - | - |
| Other Investing Activities | 168 Thousand | 558 Thousand | -32.96 Million | - | - | - |
| Financing Cash Flow | 187.07 Million | -690 Thousand | 216.9 Million | 37.49 Million | 33.86 Million | 60.67 Million |
| Debt repayment | -40.51 Million | -8.37 Million | -146 Thousand | -13.84 Million | -20 Million | -20 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -169 Thousand | -295 Thousand | -150 Thousand | -90 Thousand | -120 Thousand | -195 Thousand |
| Common Stock Issuance | 229.55 Million | 395 Thousand | 216.82 Million | 49.91 Million | 22.62 Million | 41.51 Million |
| Other Financing Activities | -1.97 Million | 7.97 Million | 223 Thousand | 1.41 Million | 31.23 Million | 19.15 Million |
| Accounts receivables | 14.43 Million | -2.66 Million | -10.6 Million | 4.84 Million | -15.3 Million | 7000.00 |
| Accounts payables | 1.51 Million | 1.19 Million | 8.47 Million | 1.87 Million | 4.59 Million | 1.74 Million |
| Inventory | -1.55 Million | -760 Thousand | 1.34 Million | -3.2 Million | -1.85 Million | -759 Thousand |
| Other working capital | 44.48 Million | -799 Thousand | -959 Thousand | 16.61 Million | 31 Thousand | -70 Thousand |
| Cash at beginning of period | 95.63 Million | 178.74 Million | 45.05 Million | 22.36 Million | 45.41 Million | 17.04 Million |
| Cash at end of period | 281.26 Million | 95.78 Million | 178.74 Million | 45.05 Million | 22.36 Million | 38.92 Million |
| Capital Expenditure | -3.48 Million | -2.15 Million | -156 Thousand | -362 Thousand | -213 Thousand | -108 Thousand |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | 2000.00 |
| Net cash flow / Change in cash | 185.63 Million | -82.96 Million | 133.68 Million | 22.69 Million | -23.04 Million | 21.87 Million |
| Free Cash Flow | -1.6 Million | -67.15 Million | -50.25 Million | -14.79 Million | -56.91 Million | -22.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.82 Million | -29.28 Million | -70.79 Million | -14.09 Million | -12.61 Million | -22.92 Million |
| Depreciation & Amortization | 362 Thousand | 303 Thousand | 464 Thousand | 112 Thousand | 115 Thousand | 132 Thousand |
| Deferred income taxes | - | - | 83 Thousand | 83 Thousand | 3.68 Million | 2.04 Million |
| Stock-based compensation | 8.69 Million | 12.69 Million | 12.05 Million | 3.59 Million | 3.62 Million | 1.78 Million |
| Change in working capital | 3.28 Million | -14.31 Million | 58.88 Million | -12.27 Million | -6.29 Million | 76.03 Million |
| Other non-cash items | -1.01 Million | 18.77 Million | 1.18 Million | -522 Thousand | -3.72 Million | -51 Thousand |
| Investing Cash Flow | -160.39 Million | 20.8 Million | -3.31 Million | -47.14 Million | -1.72 Million | 13.46 Million |
| Investments in PPE | -900 Thousand | -1.19 Million | -3.48 Million | -883 Thousand | -1.72 Million | -396 Thousand |
| Acquisitions | - | - | -168 Thousand | 46.26 Million | - | -13.86 Million |
| Investment purchases | -184.99 Million | - | -55.11 Million | -49.26 Million | - | -2.92 Million |
| Sales/Maturities of investments | 25.5 Million | 22 Million | 55.28 Million | 3 Million | - | 16.78 Million |
| Other Investing Activities | -159.49 Million | 22 Million | 168 Thousand | -46.26 Million | - | 13.86 Million |
| Financing Cash Flow | 329 Thousand | 115 Thousand | 187.07 Million | 218.48 Million | 10.36 Million | -36.65 Million |
| Debt repayment | - | - | -40.51 Million | -1.31 Million | -1.35 Million | -35.31 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -78 Thousand | -4.35 Million | -169 Thousand | - | - | - |
| Common Stock Issuance | 625 Thousand | 4.56 Million | 229.55 Million | 218.52 Million | 10.77 Million | 5000.00 |
| Other Financing Activities | -296 Thousand | -4.44 Million | -1.97 Million | -1.35 Million | 935 Thousand | -1.34 Million |
| Accounts receivables | 3.09 Million | -4.26 Million | 14.43 Million | -269 Thousand | 10.74 Million | -979 Thousand |
| Accounts payables | 5.06 Million | -1.43 Million | 1.51 Million | 728 Thousand | -2.88 Million | 5.94 Million |
| Inventory | 584 Thousand | -351 Thousand | -1.55 Million | 671 Thousand | -315 Thousand | -724 Thousand |
| Other working capital | -5.45 Million | -8.27 Million | 44.48 Million | -13.4 Million | -13.84 Million | 71.79 Million |
| Cash at beginning of period | 271.01 Million | 281.26 Million | 95.63 Million | 133.03 Million | 139.59 Million | 105.91 Million |
| Cash at end of period | 90.76 Million | 271.01 Million | 281.26 Million | 281.26 Million | 133.03 Million | 139.74 Million |
| Capital Expenditure | -900 Thousand | -1.19 Million | -3.48 Million | -883 Thousand | -1.72 Million | -396 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -180.24 Million | -10.25 Million | 185.63 Million | 148.22 Million | -6.56 Million | 33.83 Million |
| Free Cash Flow | -21.07 Million | -32.36 Million | -1.6 Million | -23.99 Million | -16.92 Million | 56.62 Million |
CITY
ZOMATO
BIRMF
TRGNF
AEWU
CGBS